(Q37220835)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1863880%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

review article

1 reference

title

Toxic effects of drugs used in the ICU. Antiarrhythmic agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1863880%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

author name string

Nolan PE Jr

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1863880%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Raehl CL

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1863880%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

publication date

1 July 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1863880%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

published in

Critical Care Clinics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1863880%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1863880%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1863880%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

507-520

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1863880%20AND%20SRC:MED&resulttype=core&format=json

Thyroid dysfunction during chronic amiodarone therapy

19 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Severity of cirrhosis and the relationship of alpha 1-acid glycoprotein concentration to plasma protein binding of lidocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Potential adverse drug interactions in the emergency room. An issue in the quality of care

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Hemodynamic effects of antiarrhythmic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Comparative effects of lidocaine and procainamide on acutely impaired hemodynamics.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Assessment of the risk-benefit ratio for antiarrhythmic drug use.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Mechanisms of drug-induced pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

The proarrhythmic effects of antiarrhythmic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Metabolism of procainamide and p-aminobenzoic acid in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Clinical features of amiodarone-induced pulmonary toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Procainamide and N-acetylprocainamide kinetics investigated simultaneously with stable isotope methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Clinical pharmacokinetics of verapamil, nifedipine and diltiazem

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Factors affecting quinidine protein binding in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Severe neutropenia associated with sustained-release procainamide

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

N-Acetyl-procainamide kinetics in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Kinetics of procainamide and N-acetylprocainamide in renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Comparative hemodynamic effects of procainamide, tocainide, and encainide in severe chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Respiratory and cardiac arrest after the administration of lidocaine into the central venous system

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Iatrogenic disease and the primary care physician.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Quinidine pharmacokinetics in patients with cirrhosis or receiving propranolol

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Systemic lupus erythematosus (SLE) induced by quinidine

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Absorption kinetics of procainamide in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Clinical characteristics of patients with ventricular fibrillation during antiarrhythmic drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Pharmacologic management of ventricular arrhythmias after the cardiac arrhythmia suppression trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

What is an antiarrhythmic drug? From clinical trials to fundamental concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Intravenous amiodarone for the rapid treatment of life-threatening ventricular arrhythmias in critically ill patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

N-Acetyl procainamide causing torsades de pointes

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Tocainide-associated interstitial pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Relation of amiodarone hepatic and pulmonary toxicity to serum drug concentrations and superoxide dismutase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Character of adverse effects of prophylactic lidocaine in the coronary care unit.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Side effects and complications of amiodarone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Congestive heart failure induced by six of the newer antiarrhythmic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Polymorphic acetylation of procainamide in man

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Drug therapy. Tocainide

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Amiodarone toxicity: myopathy and neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

The plasma protein binding of basic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Lidocaine plasma protein binding.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Clinical pharmacokinetics in heart failure. An updated review

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Effect of oral combination therapy with mexiletine and quinidine on left and right ventricular function

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Clinical predictors of arrhythmia worsening by antiarrhythmic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Pathology of the thyroid in amiodarone-associated thyrotoxicosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Arrhythmogenic effects of antiarrhythmic drugs: a study of 506 patients treated for ventricular tachycardia or fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Interrelationships of Hepatic Blood Flow, Cardiac Output, and Blood Levels of Lidocaine in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Safety and efficacy of intravenous quinidine

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Lidocaine Pharmacokinetics in Advanced Heart Failure, Liver Disease, and Renal Failure in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Quinidine kinetics in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Acute management of paroxysmal atrioventricular junctional reentrant supraventricular tachycardia: pharmacologic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Lethal accumulation of procainamide metabolite in severe renal insufficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Pharmacokinetic and electrophysiologic interactions of amiodarone and procainamide

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Effects on ventricular function of disopyramide, procainamide and quinidine as determined by radionuclide angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

A reevaluation of intravenous quinidine

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Gallium Lung Scintigraphy in Amiodarone Pulmonary Toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

Lidocaine kinetics predicted by indocyanine green clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2818%2930293-8

7 January 2021

10.1016/S0749-0704(18)30293-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1863880%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference